Santen Pharmaceutical Co., Ltd. - ROE

The ROE as of June 2026 (TTM) for Santen Pharmaceutical Co., Ltd. (SNPHY) is 13.15%

According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 13.15%. This represents a change of 303.47% compared to the average of 3.26% of the last 4 quarters.

Santen Pharmaceutical Co., Ltd. (SNPHY) Historical ROE (quarterly & annually)

How has SNPHY ROE performed in the past?

The mean historical ROE of Santen Pharmaceutical Co., Ltd. over the last ten years is 7.96%. The current 13.15% ROE has changed 65.28% with respect to the historical average. Over the past ten years (40 quarters), SNPHY's ROE was at its highest in in the March 2026 quarter at 5.23%. The ROE was at its lowest in in the September 2022 quarter at -9.26%.

Santen Pharmaceutical Co., Ltd. (SNPHY) ROE by Quarter and Year

Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Santen Pharmaceutical Co., Ltd. (SNPHY) Average ROE

How has SNPHY ROE performed in the past?

The current ROE of Santen Pharmaceutical Co., Ltd. (SNPHY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Santen Pharmaceutical Co., Ltd. (SNPHY) ROE vs. Peers

How is SNPHY’s ROE compared to its peers?

Santen Pharmaceutical Co., Ltd.’s ROE is less than MediPal Holdings Corporation (6.72%), less than Virbac S.A. (13.78%), less than The United Laboratories International Holdings Limited (12.65%), less than MediPal Holdings Corporation (6.72%), less than Haw Par Corporation Limited (6.34%), less than Shandong Weigao Group Medical Polymer Company Limited (6.69%), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (3.12%), less than Haw Par Corporation Limited (6.34%), less than Sundrug Co.,Ltd. (11.29%), less than Bavarian Nordic A/S (9.25%),

Build a custom stock screener for Santen Pharmaceutical Co., Ltd. (SNPHY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santen Pharmaceutical Co., Ltd. (SNPHY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.